The global legionella testing market is set to witness significant expansion, driven by growing public health awareness and the increasing prevalence of Legionella-related diseases. Valued at US$ 355.1 million in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 9.9% over the next decade, surpassing US$ 910 million by 2034.
Legionella, a bacterium responsible for severe illnesses such as Legionnaires’ disease, presents a pressing public health challenge. The diseases it causes often require intensive care and hospitalization, underlining the importance of early detection and preventive measures. Legionella testing plays a critical role in identifying contamination in water systems, enabling timely intervention to mitigate risks.
The surge in awareness regarding the prevention and management of Legionella-related disorders, combined with advancements in testing technologies, is propelling market growth. Enhanced regulatory standards and monitoring protocols for water systems in residential, industrial, and healthcare settings further contribute to the expanding demand for legionella testing solutions.
Full Report Revealed – https://www.futuremarketinsights.com/reports/legionella-testing-market
Key Takeaways:
- The legionella testing market is expected to be valued at US$ 355.1 million in 2024.
- A robust CAGR of 9.9% is projected between 2024 and 2034.
- By 2034, the market valuation is anticipated to exceed US$ 910 million.
- Growth is fueled by the rising prevalence of Legionella-related diseases and increased awareness about preventive management and safety standards.
As the need for effective water quality monitoring intensifies, the legionella testing market is positioned to play a vital role in safeguarding public health and enhancing disease prevention efforts globally.
Market Drivers
- Increasing Prevalence of Legionella-Related Disorders: The rise in cases of Legionnaires’ disease and Pontiac fever, which are caused by Legionella bacteria, is a significant driver for the need for effective testing solutions.
- Heightened Awareness of Public Health Concerns: Growing awareness about the risks associated with Legionella contamination in water systems has led to increased demand for regular testing and monitoring.
- Regulatory Requirements: Many governments and health organizations have implemented stringent regulations requiring routine legionella testing in high-risk environments such as hospitals, hotels, and industrial facilities, further driving market growth.
- Technological Advancements in Testing Methods: Innovations in testing technologies, including rapid testing methods like PCR and urine antigen tests, enhance the efficiency and accuracy of legionella detection.
- Increased Investment in Water Management Systems: As industries and healthcare facilities prioritize water safety management, investments in comprehensive water management plans that include legionella testing are on the rise.
Regional Insights
- North America: Expected to dominate the market due to high awareness levels, stringent regulations, and a significant number of reported cases of legionella-related illnesses.
- Europe: Anticipated to show substantial growth driven by regulatory mandates for legionella testing and increasing public health initiatives aimed at preventing outbreaks.
- Asia-Pacific: Projected to witness rapid growth as awareness about water safety increases and healthcare infrastructure improves across the region.
Challenges
- Cost of Testing Solutions: The initial investment required for advanced testing technologies may pose a barrier for some smaller facilities or organizations.
- Market Fragmentation: The presence of numerous small and mid-sized players can lead to intense competition, affecting pricing strategies and market share.
Competitive Landscape
Innovative entrepreneurs have used technological breakthroughs to challenge existing players of traditional testing methods in the highly competitive market sector inside the startup ecosystem.
The firms are introducing new testing solutions, like IoT-enabled monitoring devices, AI-powered analytics platforms, and quick testing kits. By providing affordable, user-friendly, and scalable solutions, they have challenged established players and gained traction with industrial sites, healthcare facilities, and other end customers.
Startups prioritizing agility, innovation, and customer-centricity are changing the market and raising competition, certainly leading to better risk management techniques and public health results.
Key developments in the Legionella Testing industry
- In May 2022, ChemREADY, launched a novel line of Legionella testing services and products for combating water-borne infections in building water systems. The move underscored the commitment to enhance public health and safety through innovative solutions.
- In March 2022, IDEXX announced a significant milestone with its Legiolert test, designed to rapidly detect Legionella pneumophila. ASTM International officially recognized the test as ‘ASTM D8429-21: Standard Test Method for Legionella pneumophila in Water Samples Using Legiolert’.
Key Companies Profiled
- Quidel Corporation
- Abbott (Alere)
- Merck KGaA
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
- Pro-lab Diagnostics Inc.
- bioMerieux
- IDEXX Corporation
- Eurofins Scientific
- Beckman Coulter Inc.
Key Segments
By Type:
- Culture Media
- Urine Antigen Testing (UAT)
- Polymerase Chain Reaction (PCR)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End User:
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- Middle East and Africa
Explore FMI’s Related Ongoing Coverage on Healthcare Market Insights Domain:
Atherosclerosis Market
Retractable Needle Safety Syringes Market
Angiographic Catheters Market
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube